Autopsy report · NCT03021915

Single Center, Prospective Controlled Pilot Study of the OvaPrime Procedure

“OvaScience, Inc. is no longer study sponsor as it is undergoing a merger. Follow-up will be conducted by sponsor-investigator Dr. Bob Casper.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Suspended: paused, and may or may not restart.
• 81 participants enrolled.

Vital statistics

Status

Suspended

Phase

Na

Sponsor

OvaScience, Inc.

Sponsor type

Industry

Conditions

Primary Ovarian Insufficiency; Poor Ovarian Response

Interventions

OvaPrime Treatment

Participants

81

Sites

1

Countries

Canada

Trials that died the same way

• Duet TRS Used in Pulmonary Resections
  “Sponsor is no longer pursuing this study” (68% match in meaning)
• Intravenous Ketamine Effects on Functional Neuroanatomy
  “Sponsor is no longer interested in funding the study” (66% match in meaning)
• AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US)
  “Sponsor no longer performing clinical studies. Will only be a manufacturer” (65% match in meaning)
• Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera
  “The study was terminated by the sponsor” (65% match in meaning)
• L-Menthol Injection as a Novel Technique During Colonoscopy
  “Sponsor/Investigator has decided to close out the study” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.